semaglutide patent date Last week's expiry of the for semaglutide—the active ingredient in Novo Nordisk's blockbuster drugs that are used to treat both diabetes and obesity—unleashed a flurry of launches of low-cost generic versions Indian pharma launches low-cost Ozempic

Anti-Inflammatory Biology Research

Losartan can help treat high blood pressure and heart failure

What this means for you If you have Aetna Medicare Advantage, your options include: Cardiovascular risk reduction indication (Wegovy's March 2024 FDA approval) Type 2 diabetes indication (if applicable) Self-pay options like NovoCare ($349/month) Bottom line: See our Medicare coverage guide for complete details

For a dual-incretin comparison, Trulicity vs Mounjaro may help place tirzepatide in context

GLP-3 vs GLP-1: Which Is Better

Clinical observations and limited published studies suggest that glutathione injections can improve hyperpigmentation and melasma symptoms in some patients